Monika Tornsen
Director/Board Member chez IMMUNIC, INC.
Profil
Monika Maria Tornsen is an Independent Director at Immunic, Inc. and President-North America at Calliditas Therapeutics AB.
She was previously Senior Vice President & General Manager-US at Sarepta Therapeutics, Inc., Vice President-Global Therapeutic at Genzyme Corp., and Chief Commercial Officer at Passage Bio, Inc. Tornsen is a graduate of the University of Lund.
Postes actifs de Monika Tornsen
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | Director/Board Member | 05/07/2022 |
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 07/01/2024 |
Anciens postes connus de Monika Tornsen
| Sociétés | Poste | Fin |
|---|---|---|
| PASSAGE BIO, INC. | Corporate Officer/Principal | 01/12/2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2019 |
Formation de Monika Tornsen
| University of Lund | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
